Cargando…

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer

BACKGROUND: Routine clinical surveillance involves serial radiographic imaging following radical surgery in localized non-small cell lung cancer (NSCLC). However, such surveillance can detect only macroscopic disease recurrence and is frequently inconclusive. We investigated if detection of ctDNA be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Muyun, Huang, Qi, Yin, Wei, Tan, Sichuang, Chen, Chen, Liu, Wenliang, Tang, Jingqun, Wang, Xiang, Zhang, Bingyu, Zou, Min, Li, Jina, Su, Wenhui, Wang, Lientu, Chin, Lihan, Yu, Fenglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523087/ https://www.ncbi.nlm.nih.gov/pubmed/33042842 http://dx.doi.org/10.3389/fonc.2020.561598

Ejemplares similares

Report on 153 sequential three-incision robotic-assisted pulmonary resections by a single surgeon: technical details and learning curve
por: Peng, Muyun, et al.
Publicado: (2020)

A novel technique for preoperative localization of pulmonary nodules using a mixture of tissue adhesive and iohexol under computed tomography guidance: A 140 patient single‐center study
por: Zhang, Bingyu, et al.
Publicado: (2021)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

Management of an Ingested Fish Bone in the Lung Using Video-Assist Thoracic Surgery: A Case Report
por: Tan, Sichuang, et al.
Publicado: (2015)

Comprehensive characterization of genomic and radiologic features reveals distinct driver patterns of RTK/RAS pathway in ground‐glass opacity pulmonary nodules
por: Yu, Fenglei, et al.
Publicado: (2022)

Angioleiomyoma of the pulmonary artery: a case report and literature review
por: Hu, Yan, et al.
Publicado: (2020)

Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules
por: Chen, Chen, et al.
Publicado: (2020)

Non-blood circulating tumor DNA detection in cancer
por: Peng, Muyun, et al.
Publicado: (2017)

Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development
por: Zheng, Leliang, et al.
Publicado: (2020)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis
por: Yang, Wei-Yu, et al.
Publicado: (2022)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
por: Zou, Kangni, et al.
Publicado: (2022)

Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
por: Li, Ningning, et al.
Publicado: (2023)

Possible Oncogenic Viruses Associated with Lung Cancer
por: Hu, Yan, et al.
Publicado: (2020)

Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer
por: Jin, Nana, et al.
Publicado: (2023)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Transient Palsy of Recurrent Laryngeal Nerve Postresection of Giant Substernal Goiter
por: Muhoozi, Rwakaryebe, et al.
Publicado: (2014)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Progressive Muscle Relaxation Improves Anxiety and Depression of Pulmonary Arterial Hypertension Patients
por: Li, Yunping, et al.
Publicado: (2015)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer
por: Xie, Biao, et al.
Publicado: (2022)

The Role of Circulating Biomarkers in Lung Cancer
por: Herath, Sayuri, et al.
Publicado: (2022)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Laparoscopic vs. Abdominal Radical Hysterectomy for Locally Advanced Cervical Cancer
por: Wang, Wenhui, et al.
Publicado: (2019)

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer
por: Guan, Xiuwen, et al.
Publicado: (2021)

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
por: Zhou, Sitong, et al.
Publicado: (2021)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma
por: Wu, Jiangtao, et al.
Publicado: (2021)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
por: Chai, Xupeng, et al.
Publicado: (2021)

Osimertinib for compound EGFR exon 19 deletion/T790M mutated lung squamous cell carcinoma
por: Peng, MuYun, et al.
Publicado: (2020)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis
por: Wu, Yuxi, et al.
Publicado: (2023)

Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations
por: Xiang, Yunhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3dg4use3pmkdfttlpitue8mi0